What Happened?
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 6% in the afternoon session after the company announced that its annual selling season is pacing toward a record level, with client commitments and anticipated remaining decisions expected to contribute 1.2 million new covered lives.
The company stated that the additions represent a record level of new covered lives for its managed fertility solution. The projected increase is scheduled to take effect through client launches during the first half of 2027. This expected total includes commitments received at the time of the announcement alongside anticipated remaining client decisions.
Is now the time to buy Progyny? Access our full analysis report here, it's free .
What Is The Market Telling Us
Progyny's shares are somewhat volatile and have had 11 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 7 months ago when the stock dropped 22% on the news that it issued a weak financial outlook for 2026 that overshadowed its fourth-quarter results.
The company's guidance for the first quarter of 2026 projected revenue of $325.5 million, falling 5.1% short of Wall Street's expectations. Furthermore, the full-year forecast for 2026 was also disappointing, with both its adjusted earnings per share and EBITDA guidance missing analyst estimates. This downbeat forecast soured investor sentiment despite Progyny reporting strong fourth-quarter 2025 results.
For that period, the company's revenue of $318.4 million grew 6.7% year-over-year and beat expectations, while its adjusted earnings per share of $0.48 came in nearly 20% ahead of consensus estimates.
Ultimately, the market focused on the weaker-than-expected projections, signaling concerns about future growth.
Progyny is up 7.3% since the beginning of the year, but at $27.61 per share, it is still trading 14.7% below its 52-week high of $32.36 from July 2026. Despite the year-to-date gain, investors who bought $1,000 worth of Progyny's shares 5 years ago would now be looking at only $467.78.
ALSO WORTH WATCHING: Nvidia's Quiet Partner.Nvidia's chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don't make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE .
